Highly publicised studies have suggested that high dose Methylprednisolone therapy is an essential treatment in most cases of spinal cord injury in spite of important related clinical complications. In common with clinicians in other countries BASCIS has carefully evaluated the information now available. The published evidence does not support the use of high dose Methyl prednisolone as a standard treatment in acute spinal cord injury.
Your local Spinal Injuries Centre will always be ready to give advice and provide support concerning any matter related to the management of patients with spinal injuries. Please do not hesitate to pick up the telephone to discuss your patient prior to referral and/or transfer to your Regional Spinal Injuries Centre.